当前位置: X-MOL 学术Asia Pac. J. Clin. Oncol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Prevalence of highly actionable mutations among Indian patients with advanced non-small cell lung cancer: A systematic review and meta-analysis
Asia-Pacific Journal of Clinical Oncology ( IF 1.9 ) Pub Date : 2022-05-30 , DOI: 10.1111/ajco.13802
Ruchir Raman 1, 2 , Varun Ramamohan 3 , Anurag Rathore 1, 2 , Deepali Jain 4 , Anant Mohan 5 , Vishal Vashistha 5, 6, 7
Affiliation  

Non-small cell lung cancer (NSCLC) remains a leading cause of cancer-related mortality in India. To clarify rates of actionable mutations, and thereby identify opportunities to improve the delivery of best available care for a large volume of patients, a comprehensive review of available data is warranted.

中文翻译:

印度晚期非小细胞肺癌患者中高度可操作突变的患病率:一项系统评价和荟萃分析

非小细胞肺癌 (NSCLC) 仍然是印度癌症相关死亡率的主要原因。为了阐明可操作突变的发生率,从而确定改善为大量患者提供最佳可用护理的机会,有必要对可用数据进行全面审查。
更新日期:2022-05-30
down
wechat
bug